Neurology News and Research

Latest Neurology News and Research

African-Americans with multiple sclerosis have lower vitamin D levels

African-Americans who have multiple sclerosis have lower vitamin D levels than African-Americans who don't have the disease, according to a study published in the May 24, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

24 May 2011

Discovery of possible new strategy for treating neurologic disorders

Johns Hopkins scientists say that a newly discovered "survival protein" protects the brain against the effects of stroke in rodent brain tissue by interfering with a particular kind of cell death that's also implicated in complications from diabetes and heart attack.

23 May 2011

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

A new study by rheumatologists at Hospital for Special Surgery in New York has shown that a powerful pro-inflammatory protein, tumor necrosis factor, can also suppress aspects of inflammation.

23 May 2011

Paralyzed man walks again

Three years ago, baseball champion Rob Summers was hit by a speeding car in Portland, Oregon which smashed into his legs and left him with appalling injuries. He was told he would spend the rest of his life in a wheelchair at best. However the 25 year old has become the first person paralyzed from the chest down to stand and take a step unaided.

22 May 2011

Wills Eye Institute and Thomas Jefferson University create new vision research center

A new vision research center based in Philadelphia will foster regional, national and global collaborations among a diverse group of exceptional clinicians and researchers working to better diagnose, treat and prevent visual diseases.

21 May 2011

HSS researchers develop new tool to compare efficacy of different brachial plexus surgical treatments

The way that clinicians report outcomes of surgery for a traumatic nerve injury involving the arm is not standardized, and it is thus difficult to compare the efficacy of different surgical treatments, according to a study by researchers at Hospital for Special Surgery (HSS) in New York.

20 May 2011

American Academy of Neurology breaks ground for new headquarters, donates 1,000 children's bike helmets

The American Academy of Neurology will provide 1,000 free bike helmets for children who attend one of the many Bike Fests in north Minneapolis this summer, beginning with the first Bike Fest this Saturday, May 21, 2011. The donation coincides with today's groundbreaking ceremony for the Academy's new headquarters in Minneapolis, across from the Guthrie Theater.

20 May 2011

Electrical disturbances in injured brain lead to poor recovery

Electrical disturbances that spread through an injured brain like tsunamis have a direct link to poor recovery and can last far longer than previously realized, researchers at the University of Cincinnati Neuroscience Institute have found.

20 May 2011

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced results from a Phase 2b trial evaluating Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic breast cancer previously treated with a bevacizumab-containing regimen, which showed that Nexavar was associated with statistically significant improvements in progression-free survival and time-to-progression.

20 May 2011

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.

19 May 2011

Bayer HealthCare to present results on investigational oncology compounds at ASCO annual meeting

Bayer HealthCare Pharmaceuticals, Inc. announced today that data evaluating several of its investigational oncology compounds will be presented in a scientific forum at the 2011 Annual Meeting of the American Society of Clinical Oncology, June 3-7, in Chicago, IL.

18 May 2011

U-M C.S. Mott Children's Hospital ranks top in best pediatric specialty rankings

The University of Michigan's C.S. Mott Children's Hospital has earned the highest rankings in the state of Michigan and is among the best in the country in pediatric specialties according to the U.S. News Media Group's Best Children's Hospital rankings.

18 May 2011

Early stages of Alzheimer’s difficult to detect: Study

According to a new study, more than half of people who develop Alzheimer's disease before the age of 60 are initially misdiagnosed as having other kinds of brain disease when they do not have memory problems. The research is published in the May 17, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

17 May 2011

Imec, VIB and KU Leuven join forces in pioneering brain research at NERF and in the Human Brain Project

Today, Flanders' ambitious brain research that may lead to better diagnosis and treatment of brain disease, new prosthesis technologies for patients with a disability, a new generation of more intelligent robots, etc. switches into higher gear. In the presence of Ingrid Lieten, Flemish Minister of Innovation, Public Procurement, the Media and Combatting Poverty, imec, VIB and K.U.Leuven officially inaugurated the NERF (Neuro-Electronics Research Flanders) labs on the Imec campus in Leuven. The Human Brain Project was also launched on this occasion, one of the projects on the shortlist of the prestigious European Flagship Programme. Through NERF and the participation of Flanders' research institutes in the Human Brain Project, Flanders shows that it is putting progressive brain research high on its research agenda.

16 May 2011

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of treatment.

16 May 2011

Genetic link for depression found: Study

Researchers have for the first time confirmed a specific genetic link to depression, according to new evidence published in the American Journal of Psychiatry on Monday. This finding was made independently by research teams in the UK and US, is expected to lead to a better biological understanding of the condition and eventually to more effective antidepressants.

15 May 2011

Evidence of damaged baby brains & inadequate anesthetic induced sleep: Conference updates

According to new studies commonly used anesthetics may be causing brain damage in people, especially babies who receive them while their brains are still developing.

15 May 2011

Losartan therapy improves muscle injury regeneration and prevents disuse atrophy

Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

12 May 2011

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Cell Therapeutics, Inc. announced that data from a study with OPAXIO, in patients with newly diagnosed high-grade gliomas, and interim results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia, will be presented at the 2011 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2011, in Chicago, Illinois. Both studies were selected for oral poster discussion sessions.

12 May 2011

Reprogrammed herpes virus can improve early cancer diagnosis

Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence.

12 May 2011

Neurology News and Research

Latest Neurology News and Research

African-Americans with multiple sclerosis have lower vitamin D levels

Discovery of possible new strategy for treating neurologic disorders

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

Paralyzed man walks again

Wills Eye Institute and Thomas Jefferson University create new vision research center

HSS researchers develop new tool to compare efficacy of different brachial plexus surgical treatments

American Academy of Neurology breaks ground for new headquarters, donates 1,000 children's bike helmets

Electrical disturbances in injured brain lead to poor recovery

Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Bayer HealthCare to present results on investigational oncology compounds at ASCO annual meeting

U-M C.S. Mott Children's Hospital ranks top in best pediatric specialty rankings

Early stages of Alzheimer’s difficult to detect: Study

Imec, VIB and KU Leuven join forces in pioneering brain research at NERF and in the Human Brain Project

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Genetic link for depression found: Study

Evidence of damaged baby brains & inadequate anesthetic induced sleep: Conference updates

Losartan therapy improves muscle injury regeneration and prevents disuse atrophy

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Reprogrammed herpes virus can improve early cancer diagnosis

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Neurology News and Research

Latest Neurology News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in